跳至主要内容
临床试验/NCT00325299
NCT00325299已完成4 期

Magnesium After Alcohol Withdrawal Treatment

Finnish Foundation for Alcohol Studies1 个研究点 分布在 1 个国家目标入组 178 人开始时间: 2006年5月12日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
178
试验地点
1
主要终点
Serum gamma-glutamyltransferase (GGT) activity

研究概览

简要总结

The primary purpose is to see if magnesium tablet supplementation will decrease elevated GGT enzyme activity in alcoholic patients immediately after they had been treated for alcohol withdrawal. The secondary aims are to find out whether supplementation decreases the activity of ASAT and ALAT enzymes, increases muscle strength, decreases blood pressure and decreases depressive symptoms among these patients.

详细描述

Magnesium (Mg) deficiency is common among alcoholics. Animal studies have shown that magnesium deficiency aggravates the hepatic damage caused by alcohol. One study on chronic alcoholics suggested that magnesium supplementation over six weeks decreases abnormally high activities of three enzymes related to liver function: serum gamma-glutamyltransferase (GGT), aspartate-aminotransferase (ASAT) and alanine-aminotransferase (ALAT), and increases muscle strength [4]. These results were, however, significant at the 5% level only when a 1-sided test was applied. It seems that magnesium supplementation may improve liver recovery after a drinking bout, but the evidence is not yet strong enough to warrant clear recommendations for clinical practice. Magnesium deficiency may also be one of the symptoms of depression and may aggravate hypertension. The primary purpose of the present randomized, parallel group, double blind trial is to see if oral magnesium supplementation will decrease elevated GGT enzyme activity in alcoholic patients immediately after they had been treated for alcohol withdrawal. The secondary aims are to find out whether supplementation decreases the activity of ASAT and ALAT enzymes, increases muscle strength, decreases blood pressure and decreases depressive symptoms among these patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
20 Years 至 64 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Admission to treatment because of an acute alcohol withdrawal
  • •Elevated serum GGT (men>80, women >50)
  • •Age 20-64 years
  • •Fixed address and a telephone to facilitate follow-up

排除标准

  • •Mg supplementation within the past two months ten 250 mg tablets or more
  • •History of heart rhythm disturbances
  • •Contraindications against Mg treatment
  • •Abnormally high serum creatinine

结局指标

主要结局

Serum gamma-glutamyltransferase (GGT) activity

次要结局

  • Aspartate-aminotransferase (ASAT) activity
  • Alanine-aminotransferase (ALAT) activity
  • Depressive symptoms
  • Blood pressure
  • Handgrip muscle strength

研究者

发起方
Finnish Foundation for Alcohol Studies
申办方类型
Other

研究点 (1)

Loading locations...

相似试验